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or pleura) in children ^ years of age may be nontypeable by standard serologic tests [22] . Data from the United Kingdom, including capsular genotyping, corroborated these prevalence figures, including 7 cases of bacteremic nontypeable H. influenzae infection in previously healthy children outside the neonatal period [23] . With universal implementation of conjugate Hib vaccination, the percentage of residual invasive H. influenzae disease attributable to nonencapsulated strains appears to be increasing. The Public Health Laboratory Service Communicable Disease Surveillance Centre in London reports that 46 (610z6) of 76 cases of invasive H influenzae disease occurring in the United Kingdom between October 1993 and September 1994 were due to nontypeable strains [24] . The specific microbial virulence factors that allow nonencapsulated H influenzae to cause serious disease remain unknown, and to our knowledge, the ability of such organisms to cause invasive disease in an animal model has never before been demonstrated.
Case History
A 30-month-old white boy was in his usual state of good health until 6 days before admission, when he developed a low-grade fever and abdominal pain. He was seen by his primary pediatrician, who noted right otitis media and prescribed amoxicillin, which was not taken because of vomiting. Three days before admission, he was seen in an emergency department, where he appeared lethargic and dehydrated with unresolved otitis media. There were no meningeal signs on examination. His peripheral leukocyte count was 21,000/mm3 with 580Zo neutrophils and 180Zo band forms. A blood sample was obtained for culture, the patient received intravenous rehydration and 50 mg/kg ceftriaxone intravenously, and was discharged home to resume amoxicillin administration.
The child continued to be irritable and listless with fever to 39.20C over the ensuing 48-72 h but was able to take liquids and amoxicillin. He was carefully examined daily by his pediatrician who, on day 6 of symptoms, noted the development of passive Serum immunoglobulin measurements were as follows: IgG = 651 mg/dL, IgM = 76 mg/dL, IgA = 57 mg/dL, and IgE = 19 lU/mL, all in the normal range for age. Complement studies showed C3 = 109 mg/dL, C4 = 38 mg/dL, and CH50 = 250 U, also in the normal range. Finally, the child was shown to mount a normal antibody response to tetanus booster (before = 0.17 IU/ mL, 4 weeks after = 2.97 lU/mL). He has remained healthy over the 18 months since his hospitalization.
The bacterium isolated from the patient's blood was further characterized. An absolute requirement of both hematin and NAD for aerobic growth on brain-heart infusion (BHI) agar was demonstrated. The colonies were not iridescent on BHI agar and spontaneously agglutinated in PBS. The organism produced indole and was able to decarboxylate ornithine but failed to hydrolyze urea, placing it in H. influenzae biotype V according to the scheme of Kilian [25] .
Methods
Bacterial strains and cultures. Strain EIA is a spontaneous streptomycin-resistant mutant of H. influenzae type b (Eagan), originally isolated from a child with meningitis. It has been shown to establish bacteremia and meningitis in infant rats after intraperitoneal or intranasal inoculation [26] . Strain R906 [27] , also identified as Goodgal, is a derivative of strain Rd, a capsule gene deletion mutant of a type d H. influenzae known to be avirulent in the infant rat model [28] . Strain Ull is a spontaneous streptomycinresistant mutant of nonencapsulated strain Ul, also identified as Ramirez [26] , and is unable to produce sustained bacteremia in infant rats. INT1 is the nontypeable H. influenzae isolated from the 30-month-old child with meningitis described herein. INT la represents the same strain isolated from the blood of an infant rat 48 h after intraperitoneal inoculation. All bacterial strains were grown at 370C in BHI broth (Difco) supplemented with NAD and hematin (sBHI) as described [29] . For plating, the broth was solidified with 207o agar (Difco).
Estimation of capsular polysaccharide. Bacteria were grown to midlog phase (A6m = 0.2) or overnight and harvested by centrifugation at 12,000 g at 40C for 15 min, and the supematants were frozen at -70oC before ELISA. Inoculation procedure. Bacteria were grown in sBHI broth to a density of 108ZmL, harvested by centrifugation as above, resuspended in PBSG, and diluted in the same solution to the desired density. A volume of 0.1 mL was used for intraperitoneal inoculation of both weanling and infant rats; randomized litters received injections of one H. influenzae strain at a single inoculum.
Determination of bacteremia and meningitis. After inoculation, the 5-day-old rats were returned to their surrogate mothers and examined every 12 h. Animals that died were removed from the litter. At 48 h after inoculation, a 0.2-mL sample of blood was obtained from each infant rat by direct cardiac puncture using standard sterile technique. Serial dilutions were plated and incubated overnight at 370C, and colony-forming units were counted to determine the level of bacteremia.
For weanling males, at 48-54 h the animals were anesthetized with 207o halothane and external jugular vein blood (0.1 mL) was obtained and added to 1 mL of sBHI broth. After overnight incubation, the turbid tubes were streaked to BHI plates, and NAD and hematin strips were used to verify the presence of H. influenzae. Cisternal CSF was obtained by the method of Moxon and Murphy [33] . In brief, a skin flap was reflected over the cistema magna and the connective tissue scraped aside with a dental pick. The membrane was punctured with a 25-gauge needle, and as the Vshaped cavity filled with CSF, 50 pL was withdrawn and added to 1 mL of sBHI broth. After overnight incubation, turbid cultures were processed as above.
Transformation with high-molecular-weight INT1DNA. Highmolecular-weight DNA was prepared from INT1 and strain Ull by the method of Hull et al. [34] . Strain R906 was rendered competent by the M-IV nongrowth media procedure of Herriott et al. [35] . Competent R906 (109 cfu in 1 mL) were exposed for 30 min to 1 -2 pg of DNA from INT1 or Ul 1 or no DNA. The cells were then pelleted at 40C in a microcentrifuge, resuspended in 1 mL of warmed sBHI broth, and incubated for 1 h at 370C. A 0.1-mL aliquot (~108 cfu) was used for intraperitoneal inoculation of weanling rats, which were then evaluated for development of bacteremia and meningitis at 48 h as described above. Molecular cloning studies and further in vivo testing have begun in our laboratory in an attempt to identify the precise nature of the virulence factor(s) that allow INT1 to produce invasive disease.
Results

